Raia Drogasil
R$19.50Change from previous close: +4.00%Absolute change: +R$0.75
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- R$33.2B
- Enterprise value
- R$40.69B
- P/E (trailing 12 months)
- 22.3
- Forward P/E
- 16.3
- PEG
- 0.27
- Price/book
- 4.55
- Price/sales
- 0.71
- EV/EBITDA
- 10.5
- EV/revenue
- 0.87
Profitability and growth
- Gross margin
- 30.3%
- Operating margin
- 7.6%
- Net margin
- 2.9%
- ROE
- 20.0%
- ROA
- 7.8%
- Revenue growth (year over year)
- 9.8%
- Earnings growth (year over year)
- 14.4%
Financial health
- Total cash
- R$652.95M
- Total debt
- R$8.59B
- Debt/equity
- 1.18
- Current ratio
- 1.41
- Quick ratio
- 0.48
Dividends
- Annual dividend per share
- R$0.44
- Dividend yield
- 2.4%
- Payout ratio
- 51.9%
- Ex-dividend date
- July 6, 2026
Analysts and estimates
- Average price target
- R$25.77
- Median price target
- R$26.00
- High price target
- R$30.00
- Low price target
- R$18.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- R$1.17
- EPS estimate, current year
- R$0.91
Shares and trading
- Beta
- 0.02
- Average volume
- 10.31M
- Shares outstanding
- 1.75B
- Float
- 1.31B
- Institutional ownership
- 53.5%
- Insider ownership
- 25.3%